J&J Enters Robot Surgery Race
The FDA cleared Johnson & Johnson's Ottava surgical robot, marking its entry into the growing robotic surgery market.
Johnson & Johnson (J&J) just joined the future of surgery. The Food and Drug Administration (FDA) cleared J&J's Ottava Robotic Surgical System. This approval means J&J can now sell its robot for soft tissue surgeries. It puts J&J in a major competition with other companies.
Two other big players are already in this space. Intuitive Surgical and Medtronic both have robotic systems. J&J says Ottava will start a "next era in surgery." The company believes its robot will change how doctors operate.
Robotic surgery helps doctors perform complex tasks. These systems may offer more precision and less pain for patients. This new approval could mean more choices for hospitals and patients seeking advanced medical care.
Source: FierceBiotech
More from Biotech
